National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting, 42449-42450 [2010-17850]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 139 / Wednesday, July 21, 2010 / Notices
For information, contact Ester
Sumartojo, Ph.D., Designated Federal
Officer, BSC, NCBDDD/NCBDDD,
Department of Health and Human
Services, 1600 Clifton Road, M/S E87,
Atlanta, Georgia 30341, telephone (404)
498–3072, or fax (404) 498–3070.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: July 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–17758 Filed 7–20–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
erowe on DSKG8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
A—Cancer Centers.
Date: August 5–6, 2010.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Gail J Bryant, MD, Medical
Officer, Resources and Training Review
Branch, Division of Extramural Activities,
National Cancer Institute, 6116 Executive
Blvd., Room 8107, MSC 8328, Bethesda, MD
20892–8328, (301) 402–0801, gb30t@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
VerDate Mar<15>2010
15:19 Jul 20, 2010
Jkt 220001
42449
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 15, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Dated: July 15, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–17819 Filed 7–20–10; 8:45 am]
[FR Doc. 2010–17815 Filed 7–20–10; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Clinical Trials
and Translational Research Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee.
Date: September 21, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: Strategic Discussion on Clinical
and Translational Research Programs and
Updates of the Implementation of the
Clinical Trials and Translational Research
Working Group Reports.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Sheila A. Prindiville, MD,
MPH, Director, Coordinating Center for
Clinical Trials, Office of the Director,
National Cancer Institute, National Institutes
of Health, 6120 Executive Blvd., 3rd Floor
Suite, Bethesda, MD 20892, 301–451–5048,
prindivs@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, July 23,
2010, 8:30 a.m. to July 23, 2010, 5:30
p.m., The River Inn, 924 25th Street,
NW., Washington, DC 20037 which was
published in the Federal Register on
July 1, 2010, 75 FR 38111.
The meeting will be held August 6,
2010. The meeting time and location
remain the same. The meeting is closed
to the public.
Dated: July 15, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–17821 Filed 7–20–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism, Special
Emphasis Panel, Review of RFA AA10–007 &
AA10–008 Gut-Liver-Brain Interactions in
Alcohol Induced Pathogenesis.
Date: August 10–12, 2010.
Time: 8 a.m. to 5 p.m.
E:\FR\FM\21JYN1.SGM
21JYN1
42450
Federal Register / Vol. 75, No. 139 / Wednesday, July 21, 2010 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892. (Virtual
Meeting)
Contact Person: Philippe Marmillot, PhD,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room
2017, Bethesda, MD 20852, 301–443–2861,
marmillotp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Room 2121, Bethesda, MD 20892, 301–443–
2369, lgunzera@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards, National
Institutes of Health, HHS)
Dated: July 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–17855 Filed 7–20–10; 8:45 am]
BILLING CODE 4140–01–P
Dated: July 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2010–17850 Filed 7–20–10; 8:45 am]
Office of the Director, National
Institutes of Health; Notice of Meeting
National Institutes of Health
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
erowe on DSKG8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Epidemiology, Prevention
and Behavior Research Review
Subcommittee.
Date: October 27–28, 2010.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Lorraine Gunzerath, PhD,
MBA, Scientific Review Officer, National
Institute on Alcohol Abuse and Alcoholism,
Office of Extramural Activities, Extramural
Project Review Branch, 5635 Fishers Lane,
VerDate Mar<15>2010
15:19 Jul 20, 2010
Jkt 220001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Council
of Councils.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), title 5 U.S.C., as amended
because the premature disclosure of
other and the discussions would likely
to significantly frustrate implementation
of recommendations.
Name of Committee: Council of Councils.
Date: August 17, 2010.
Open: 11 a.m. to 12 p.m.
Agenda: Discussion of Roadmap
Transformative R01 Program and Review
Process. See https://grants.nih.gov/grants/
guide/rfa-files/RFA-RM-08-029.html.
Toll-free dial-in number (US and Canada):
888–285–2623. Conference code: 86739025.
Place: National Institutes of Health,
Building 1, Room 260, 1 Center Drive,
Bethesda, MD 20892 (Telephone Conference
Call).
Closed: 12 p.m. to 1:30 p.m.
Agenda: Second-level review of Roadmap
Transformative R01 Program grant
applications.
Place: National Institutes of Health,
Building 1, Room 260, Center Drive,
Bethesda, MD 20892.
Contact Person: Robin Kawazoe, Executive
Secretary, Council of Councils and Deputy
PO 00000
Frm 00077
Fmt 4703
Sfmt 9990
Director, Division of Program Coordination,
Planning, and Strategic Initiatives, Office of
the Director, National Institutes of Health,
Building 1, Room 260, 1 Center Drive,
Bethesda, MD 20892,
kawazoer@mail.nih.gov, (301) 402–9852.
Additional information, including the
meeting agenda is available on the Council of
Council’s home page:
https://dpcpsi.nih.gov/council/.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: July 13, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–17702 Filed 7–20–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, July 28,
2010, 8 a.m. to July 30, 2010, 2 p.m.,
National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
which was published in the Federal
Register on June 15, 2010, 75 FR 33816.
The meeting will be held July 27,
2010 to July 28, 2010. The meeting time
and location remain the same. The
meeting is closed to the public.
Dated: July 15, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–17861 Filed 7–20–10; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\21JYN1.SGM
21JYN1
]]>Agencies
[Federal Register Volume 75, Number 139 (Wednesday, July 21, 2010)]
[Notices]
[Pages 42449-42450]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-17850]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Alcohol Abuse and
Alcoholism, Special Emphasis Panel, Review of RFA AA10-007 & AA10-
008 Gut-Liver-Brain Interactions in Alcohol Induced Pathogenesis.
Date: August 10-12, 2010.
Time: 8 a.m. to 5 p.m.
[[Page 42450]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5635 Fishers Lane,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Philippe Marmillot, PhD, Scientific Review
Officer, National Institute on Alcohol Abuse and Alcoholism,
National Institutes of Health, 5635 Fishers Lane, Room 2017,
Bethesda, MD 20852, 301-443-2861, marmillotp@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research and Research Support Awards, National Institutes of Health,
HHS)
Dated: July 14, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-17850 Filed 7-20-10; 8:45 am]
BILLING CODE 4140-01-P
